The Oncology Institute, Inc.

NASDAQ:TOI

0.3 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12018 Q4
Operating Activities:
Net Income -12.679-16.272-15.314-17.419-16.897-29.998-9.502-2.674-5.45319.286-10.156-2.983.205-0.996-8.5093.0151.018-9.846-1.994
Depreciation & Amortization 1.5181.4891.5771.6981.3291.2691.1921.1341.0980.9870.9190.850.7940.7770.790.7920.8010.7950.764
Deferred Income Tax 0.0990-0.1260.08-0.004-0.026-0.4460.052-0.0490.182.296-3.759-00.22100000.731
Stock Based Compensation 3.3874.0874.0794.6594.1074.9656.076.5466.5148.55324.3820.0590.0510.0420.0380.0360.0420.0340
Change In Working Capital -3.406-2.7326.446-1.1111.801-4.777-5.173-7.6010.271-7.993-12.6783.079-5.290.4020.999-4.5632.061-2.696-2.785
Accounts Receivables 4.761-16.2174.006-2.081-0.435-6.141-5.07-6.015-4.54-4.662-2.401-1.244-0.55-2.621-0.553-1.407-2.1820.484
Change In Inventory 0.2322.124-1.472-0.006-1.914-0.9930.852-0.851-0.401-1.332-0.502-1.068-0.2820.010.3170.4280.131-1.341-0.049
Change In Accounts Payables -5.4596.3571.0960.211.1772.574-1.783-2.7461.305-2.963-3.3355.2990.4770.4743.756-4.600.0523.222
Other Working Capital -2.945.0042.8160.7662.9734.560.8282.0113.9070.962-10.8411.248-4.240.468-2.7570.0373.3380.827-6.442
Other Non Cash Items 2.40912.346-0.5553.7831.00413.115-6.138-17.856-12.76-37.994-28.0980.073-5.8910.0188.519-2.956-9.9621.7530
Operating Cash Flow -15.66-15.883-3.893-8.31-8.66-15.452-13.997-20.399-10.379-16.981-23.335-2.679-7.130.4641.009-4.504-6.03710.04-3.283
Investing Activities:
Investments In Property Plant And Equipment -1.826-0.61-0.861-0.93-0.937-1.839-1.995-1.19-1.342-1.002-0.871-0.95-0.607-0.619-0.358-0.267-0.233-0.336-0.37
Acquisitions Net 00-0.156-8.639-4.3-20.24-0.470.813-8.920-8.280-0-0.82700-0.1503.185
Purchases Of Investments 000.0880.0640.012-9.759-30.106-87.40200000000000
Sales Maturities Of Investments 20.00219.99812.5568.57530.12829.99930.57686.58900000000000
Other Investing Activites 019.99812.6448.63930.1420.24-30.576-86.58900-000.30221.156-221.7810-7.50
Investing Cash Flow 18.17619.38811.6277.70924.90318.401-32.571-87.779-10.262-1.002-9.151-0.949-0.608-1.446221.156-221.781-0.383-7.8362.815
Financing Activities:
Debt Repayment -0.009-0.009-0.01-0.01-0.063-0.018-0.019-0.013-0.013-0.013-5.133-0.009-2.005-0.104-0.098-0.102-4.888-7.4930
Common Stock Issued 0.0020.0730.1130.013000.4420.0790.3370200-202000000
Common Stock Repurchased 000-0.125-0.89400-9-90000000000
Dividends Paid 00-0.0130000000000000000
Other Financing Activities -2.14-1.002-1.884-0.621-1.644-1.691-1.27114.329-11.009-1.644121.2610-2.52.50.055.9430-0.3430
Financing Cash Flow -2.147-0.938-1.781-0.756-2.601-1.709-0.847105.395-10.685-1.657136.128-0.009-4.50522.396-0.049-0.1024.8887.150
Other Information:
Effect Of Forex Changes On Cash 000.011-9.572-25.004000005.081-11.327-0-21.7582.421-2.421000
Net Change In Cash 0.3692.5675.953-1.35713.6421.24-47.415-2.783-31.326-19.64103.642-3.637-12.24321.4144.999-9.27-1.53211.776-0.468
Cash At End Of Period 36.42436.05533.48827.53528.89215.2514.0161.42564.20895.534115.17411.53215.16927.4125.9980.99910.26811.8010.037